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ABSTRACT 
The blood-brain barrier (BBB) is a selective barrier that help to maintain brain homeostasis, however it also creates an 
obstacle to drug delivery. For years, in vivo animal models have been widely used for BBB studies and drug evaluations. 
Although these techniques are considered the gold standard, 80% of drug candidates that were successful in animal models 
later failed in clinical trials. For that reason, a cost-effective in vitro BBB model that adequately reflects human in vivo 
conditions is required. Here we developed a 3D microfluidic model of the BBB by self-organized vascular network including 
(iPS)-derived endothelial cells, human brain pericytes, and astrocytes.  
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INTRODUCTION 
The blood-brain barrier (BBB) is a complex structure necessary for separating the brain 
from blood circulation maintaining neural homeostasis and protecting against pathogens.  
However, this selective barrier also prevents efficient drug delivery targeting specific 
brain areas, preventing treatments of neurodegenerative diseases and cancers [1]. 
Furthermore, traditional and animal models failed to reproduce the complexity of brain 
barriers, conducting to misleading results in clinical trials.  
 To overcome those limitations, we developed an innovative 3-dimensional BBB self-
organized microvascular network model via vasculogenesis that accurately replicates the 
anatomical neurovascular organization observed in vivo.  
 
METHODS  
A PDMS microfluidic model including human induced pluripotent stem cells-derived 
endothelial cells (iPSC-ECs), human brain pericytes, and astrocytes as self-assembled 
vascular networks. RT-PCR, vascular permeability and immunocytochemistry assays were 
performed.  
 
RESULTS  
Gene expression of tight junctions (ZO-1, occludin, and claudin-5), extra-cellular matrix proteins (Laminin and Collagen 
IV), and membrane transporters (PG-P, LAT1, LRP1) was higher in tri-culture condition consistently with quantitative 
immunocytochemistry analysis indicating BBB-like maturation. Laser confocal microscopy validated microvessel-
pericytes/astrocytes contact-interactions.  Characterization of microvascular network parameters as vascular diameter, branches 
length and vascular network area coverage were lower when including pericytes and astrocytes. This revealed that 
morphological changes were induced by not only the secretion of pro-angiogenic and vasculogenic growth factors but also 
contact signaling between cells. The BBB model exhibited perfusable and selective microvasculature, showing permeability 
coefficient comparable to previous models [2], (10 kDa FITC-Dextran: 2.2×10-7 cm/s; 40 kDa FITC-Dextran: 8.9×10-8 cm/s).  
 
  
Figure 1.  Confocal image of 3D 
BBB microvascular network 
model with IPSC-ECs (green), 
brain pericytes (red) and 
astrocytes (violet). Bar scale 
100 µm. 
DISCUSSIONS 
Our BBB microfluidic model has the advantages that all three cell types are seeded simultaneously into a single gel region, 
producing a perfusable vascular network with permeabilities lower than those of other published models. The contribution of 
co-culture with pericytes and astrocytes also improved BBB formation and integrity and upregulation of tight junction proteins 
and membrane transporters by the iPS endothelial cells, highlighted as potential targets to enhance the penetration of drugs into 
the brain.  
 
CONCLUSIONS  
This robust 3D BBB microvascular model could be potentially applied to patient-specific and neurodegenerative diseases 
modelling, offering a novel platform to study both drug transport for preclinical screening as well as neurovascular functions 
within a physiologically-relevant BBB microvasculature.  
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